Amredobresib
Products
Description
Amredobresib (BI894999) is an oral inhibitor of BET, which acts as an acetyl-lysine mimic. It prevents the bromodomains BRD4-BD1 and BRD4-BD2 from binding to acetylated histones, with an IC50 of 5 nM for BRD4-BD1 and 41 nM for BRD4-BD2.
Specifications
| Manufacturer Cat# | E4609 |
|---|---|
| Target | Epigenetic Reader Domain |